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Antibiotic Resistance: A Global Crisis
The discovery of antibiotics was heralded as one of the greatest 
medical discoveries in modern history and the drugs quickly became 
the cornerstone of modern medicine. Yet after 80 years of significant 
overuse in human medicine and agriculture, antibiotics are losing 
their effectiveness. It is estimated that up to 50% of all prescribed 
antibiotics are either not needed—such as antibiotics given to treat 
viral infections—or are not properly “matched” to the bacteria they’ve 
been prescribed to treat, and therefore are not as effective as they 
could be.2  This has led to a sharp increase in drug-resistant infections 
around the world. As a result, antibiotic resistance is now one of the 
greatest public health threats of our time, with substantial impacts on 
people, health care systems and economies worldwide. Without 
“Without urgent, 
coordinated action by 
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the world is headed 
for a post-antibiotic 
era, in which common 
infections and minor 
injuries, which have 
been treatable for 
decades can once  
again kill.”1
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urgent action, it is estimated that by 2050, 10 million people a year will 
die from drug-resistant infections and $100 trillion in global economic 
productivity will have been lost over that time period.3
Addressing antibiotic resistance requires a coordinated global 
response. In September 2016, the United Nations General Assembly 
took up the issue for the first time by adopting a UN declaration4, 
signed by all 193 member states, on the importance of combating 
antibiotic resistance. It noted: “no one country, sector or organization 
can address this issue alone”5 and called for better promotion of 
existing diagnostic tests as well as the need to develop and fund new 
diagnostic tools.6
What are Diagnostic Tests? 
Diagnostic tests are a critical component in any strategy to reduce 
antibiotic resistance. Diagnostic tests can help clinicians decide 
whether an antibiotic will cure an infection and which specific drug will 
work best. This could dramatically reduce unnecessary antibiotic use 
and improve patient care. 
There are many safe and effective diagnostic tests available to health 
care professionals today. These tests—performed in laboratories, at 
the hospital bedside, in medical clinics, and in the home—improve 
quality of care, promote wellness and often reduce health care costs.
Diagnostic tests are an integral component of health care and an 
important part of the fight against antimicrobial resistance. Diagnostic 
tests can be used to quickly distinguish between infections that require 
treatment and those that do not—such as viral infec-
tions—in order to determine the appropriate treatment 
strategy. Rapid, point-of-care tests can quickly inform 
physicians’ decisions on what antibiotics, if any, are 
most appropriate for the treatment of their patients—
before they leave the physicians’ offices. These tests 
are critical in defining the pathway for improved patient 
care. More frequent use of diagnostic tests to inform 
Diagnostic  
Tests Can:
Improve  
patient care 
Decrease  
overall medical costs
Ensure  
doctors prescribe the 
correct antibiotics at the 
right time
Improve  
the judicious use of 
antibiotics, especially in 
outpatient settings where 
antibiotics are often 
overused
Reduce  
misuse of antibiotics
Identify  
drug-resistant organisms 
to enable patient isolation, 
decontamination,  
and reduce spread  
of infections
Revitalize  
antibiotics that have been 
abandoned due to high 
rates of resistance
treatment decisions will 
reduce unnecessary use 
of antibiotics and therefore 
slow down antimicrobial 
resistance. Furthermore, 
the value of diagnostic 
tests continues to increase 
as manufacturers develop 
new and improved tests 
that help doctors quickly 
identify infections, predict 
health outcomes, and 
choose the most effective 
treatment options.
The Role of Diagnostics in Curbing Resistance
In many cases, health care professionals prescribe antibiotics based on just their professional 
judgment and immediate assessment of a patient. As a result, patients frequently are given 
antibiotics that are unnecessary or may be ineffective.8 In fact, at least 30% of antibiotics prescribed 
in the United States are unnecessary,9 and the percentage of antibiotics unnecessarily prescribed 
in the rest of the world is estimated to be even higher. Diagnostic 
tests can help health care professionals determine when to start, 
and importantly, when to stop antibiotics, ensuring that patients 
only receive these powerful drugs when they need them. This could 
substantially improve patient care and help slow antibiotic resistance.
Antimicrobial resistance is a massive global public health challenge,  
and the increased use of currently available diagnostic tests and  
the development of new, rapid diagnostic tests are critical parts of  
the solution. 
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“Today, antibiotics 
are rarely prescribed 
based on a definitive 
diagnosis. Diagnostic 
tests can show whether 
or not an antibiotic is 
actually needed, and 
which one. Having rapid, 
low-cost, and readily 
available diagnostics is 
an essential part of the 
solution to this urgent 
problem.”7
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